Addressing medicine shortages in Europe

29 September 2017

Report

Position paper Reading list Commentary + EIU document

2017 Market Review – Biosimilar Medicines Markets – Policy Overview

12 September 2017

Report

Value Added Medicines: Time to Adjust the HTA Decision Frameworks

5 September 2017

Report

Global Healthcare Trends and Outlook

15 June 2017

Report

The Impact of Biosimilar Competition in Europe

8 May 2017

Report

ISPOR 2016 EU – Value Added Medicines

18 November 2016

Policy, Report

Healthcare System Inefficiencies Related To Medicines: Any Potential Room For […]

Market Review – European Generic Medicines Markets 2016

10 November 2016

Report

Simon-Kucher. Policy Requirements for a Sustainable Biosimilar Market (September 2016)

19 September 2016

Report

IMS – The Impact of Biosimilar Competition (2016)

1 June 2016

Report

Value Added Medicines: Rethink, Reinvent & Optimize Medicines, Improving Patient Health & Access

31 May 2016

Policy, Report